News

Pulmonary Fibrosis Foundation’s Care Center Network Expands To 33 States

The Pulmonary Fibrosis Foundation announced David Lederer, M.D., M.S., Senior Medical Advisor for Education and Awareness, was honored with the John W. Walsh PAR Award for Excellence on Sunday, May 19, at the American Thoracic Society International Conference in Dallas.

The Pulmonary Fibrosis Foundation announced data from four studies exploring the symptoms and treatments associated with this progressive and debilitating form of lung disease.

The Pulmonary Fibrosis Foundation’s PFF Summit, the world’s largest healthcare conference on pulmonary fibrosis (PF), will unite the PF community and provide the latest on research and care, including how precision medicine via DNA sequencing and targeted treatments may lead to better outcomes.

The medical advisory board of the Pulmonary Fibrosis Foundation, the nation’s leading patient education and advocacy organization representing the more than 200,000 Americans with pulmonary fibrosis, has issued an updated statement on the use of stem cell/cell-based therapies.

Responsum for PF features a searchable database of over 500 article summaries, curated for the pulmonary fibrosis community.